Aganirsen Uses, Dosage, Side Effects and more
Aganirsen is under investigation in clinical trial NCT02947867 (Trial of Aganirsen in iCRVO Patients at Risk of Developing NVG).
| Attribute | Details |
|---|---|
| Trade Name | Aganirsen |
| Generic | Aganirsen |
| Aganirsen Other Names | Aganirsen |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
